Register Free
Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Neurology Diabetes / Metabolic Rheumatology Gastroenterology Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Clinical Starter Packs

Curated starting points for high-yield specialties

Each pack brings together a key guideline, a current trial, a Drug Science explainer, and a relevant education item so clinicians can get oriented fast.

6 specialties 4 content pillars per pack Open clinical learning

Starter Packs

Use these as orientation pages for a topic area, then continue into the full specialty hub, Trial Radar, Drug Science and education library.

Specialty Pack

Diabetes / Metabolic

Specialty hub →
Key Guideline

2022 EASD/ESC Guidelines on Diabetes and Cardiovascular Disease

This EASD guideline addresses 2022 EASD/ESC Guidelines on Diabetes and Cardiovascular Disease in Diabetes / Metabolic.

View guideline →
Trial Radar

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)…

View trial →
Drug Science

HMG-CoA Reductase — Statins

HMG-CoA Reductase — Statins is a clinically relevant Drug Science explainer.

Open explainer →
Education

NICE NG28: Type 2 Diabetes in Adults — 2024 Update

Apply NICE NG28 updates to type 2 diabetes treatment sequencing, including when SGLT2 inhibitors or GLP-1 receptor agonists should be…

Start learning →
Latest Clinical Brief New light shed on who benefits most from weight-loss jabs
Explore Diabetes / Metabolic Follow this specialty
Specialty Pack

Cardiology / Cardiovascular

Specialty hub →
Key Guideline

EMA Guideline on Clinical Investigation of Medicinal Products for Heart Failure

This EMA guideline addresses EMA Guideline on Clinical Investigation of Medicinal Products for Heart Failure in Cardiology / Cardiovascular.

View guideline →
Trial Radar

Test-retest Study With [18F]FBB in Cardiac Amyloidosis

A study testing whether PET scans reliably detect amyloid buildup in hearts of patients with cardiac amyloidosis.

View trial →
Drug Science

HMG-CoA Reductase — Statins

HMG-CoA Reductase — Statins is a clinically relevant Drug Science explainer.

Open explainer →
Education

Cardiovascular Risk Reduction — Latest Evidence 2024

Use QRISK3 and clinical risk factors to identify patients who need lipid-lowering intensification.

Start learning →
Latest Clinical Brief 3D heart to let surgeons practise baby’s vital heart operation
Explore Cardiology / Cardiovascular Follow this specialty
Specialty Pack

Respiratory / COPD / Asthma

Specialty hub →
Key Guideline

Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres: early-use assessment

Digital spirometry algorithms can improve diagnostic accuracy for asthma and COPD in primary care and community diagnostic centres, potentially reducing…

View guideline →
Trial Radar

A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK) is Recruiting • Phase II • Respiratory…

View trial →
Drug Science

CFTR Modulation

CFTR Modulation is a clinically relevant Drug Science explainer.

Open explainer →
Education

NICE NG185: COVID-19 Rapid Guideline — Long-term Effects

Distinguish ongoing symptomatic COVID-19 from post-COVID-19 syndrome using NICE NG185 definitions.

Start learning →
Latest Clinical Brief File on 4 Investigates
Explore Respiratory / COPD / Asthma Follow this specialty
Specialty Pack

Oncology

Specialty hub →
Key Guideline

EMA Reflection Paper on Extrapolation of Efficacy in Oncology

This EMA guideline addresses EMA Reflection Paper on Extrapolation of Efficacy in Oncology in Oncology.

View guideline →
Trial Radar

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

GEN1042 antibody tested alone and combined with pembrolizumab, with or without chemotherapy, in patients with solid tumours.

View trial →
Drug Science

BRAF/MEK Pathway — Melanoma

BRAF/MEK Pathway — Melanoma is a clinically relevant Drug Science explainer.

Open explainer →
Education

Coming into focus

We’re still building this layer for Oncology.

Latest Clinical Brief Prince William praises £20m milestone for Bowelbabe fund
Explore Oncology Follow this specialty
Specialty Pack

Rheumatology

Specialty hub →
Key Guideline

2023 EULAR Recommendations for Systemic Lupus Erythematosus

This EULAR guideline addresses 2023 EULAR Recommendations for Systemic Lupus Erythematosus in Rheumatology.

View guideline →
Trial Radar

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Trial comparing treatment options for lupus patients not responding adequately to current standard steroids and immunosuppressive drugs.

View trial →
Drug Science

IL-6 Signalling

IL-6 Signalling is a clinically relevant Drug Science explainer.

Open explainer →
Education

JAK Inhibitors: Updated Safety Signals, Patient Selection and Post-ORAL Surveillance

Recorded webinar focused on JAK inhibitors in rheumatology and immune-mediated inflammatory disease.

Watch webinar →
Explore Rheumatology Follow this specialty
Specialty Pack

Infectious Disease

Specialty hub →
Key Guideline

2022 ESCMID Guidelines on Candidaemia and Invasive Candidiasis

This ESCMID guideline addresses 2022 ESCMID Guidelines on Candidaemia and Invasive Candidiasis in Infectious Disease.

View guideline →
Trial Radar

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa is Recruiting • Phase II • Infectious Disease • NCT07170917.

View trial →
Drug Science

IL-6 Signalling

IL-6 Signalling is a clinically relevant Drug Science explainer.

Open explainer →
Education

NICE NG185: COVID-19 Rapid Guideline — Long-term Effects

Distinguish ongoing symptomatic COVID-19 from post-COVID-19 syndrome using NICE NG185 definitions.

Start learning →
Latest Clinical Brief Hepatitis C infections in people who inject drugs continue to fall
Explore Infectious Disease Follow this specialty
Stay Updated

Follow your clinical interests

Choose guideline, trial, Drug Science, research and education updates across the specialties you care about.

Set Preferences →